Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_provenance.
- NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_assertion description "[These results validate myostatin inhibition as a therapeutic approach to muscle wasting diseases such as muscular dystrophy, sarcopenic frailty of the elderly and amylotrophic lateral sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_provenance.
- NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_assertion evidence source_evidence_literature NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_provenance.
- NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_assertion SIO_000772 16246158 NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_provenance.
- NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_assertion wasDerivedFrom befree-2016 NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_provenance.
- NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_assertion wasGeneratedBy ECO_0000203 NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_provenance.
- befree-2016 importedOn "2016-02-19" NP519284.RADz19r2KJpK0TdeoHDQGbgHQ3adWB8HNUI881oI4_YMg130_provenance.